Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2019 Oct;221(4):304-310.
doi: 10.1016/j.ajog.2019.02.046. Epub 2019 Feb 25.

Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies

Affiliations
Meta-Analysis

Elective induction of labor at 39 weeks compared with expectant management: a meta-analysis of cohort studies

William A Grobman et al. Am J Obstet Gynecol. 2019 Oct.

Abstract

Background: Elective induction of labor at 39 weeks among low-risk nulliparous women has reduced the chance of cesarean and other adverse maternal and perinatal outcomes in a randomized trial, although its clinical effectiveness in nonresearch settings remains uncertain.

Objective: To perform a systematic review of observational studies that compared elective induction of labor at 39 weeks among nulliparous women with expectant management and to use meta-analytic techniques to estimate the association of elective induction with cesarean delivery, as well as other maternal and perinatal outcomes.

Study design: Studies were eligible for this meta-analysis only if they: (1) were observational; (2) compared women undergoing labor induction at 39 weeks with women undergoing expectant management beyond that gestational age; (3) included women in the induction group only if they had no other indication for labor induction at 39 weeks; and (4) provided data specifically for nulliparous women. The predefined primary outcome was cesarean delivery, and secondary outcomes representing other maternal and perinatal morbidities also were evaluated. Outcome data from different studies were combined to estimate pooled relative risks with 95% confidence intervals using random-effects models.

Results: Of 375 studies identified by the initial search, 6 cohort studies, which included 66,019 women undergoing elective labor induction at 39 weeks and 584,390 undergoing expectant management, met inclusion criteria. Elective induction of labor at 39 weeks was associated with a significantly lower frequency of cesarean delivery (26.4% vs 29.1%; relative risk, 0.83; 95% confidence interval, 0.74-0.93), as well as of peripartum infection (2.8% vs 5.2%; relative risk, 0.53; 95% confidence interval, 0.39-0.72). Neonates of women in the induction group were less likely to have respiratory morbidity (0.7% vs 1.5%; relative risk, 0.71; 95% confidence interval, 0.59-0.85); meconium aspiration syndrome (0.7% vs 3.0%; relative risk, 0.49; 95% confidence interval, 0.26-0.92); and neonatal intensive care unit admission (3.5% vs 5.5%; relative risk, 0.80; 95% confidence interval, 0.72-0.88). There also was a lower risk of perinatal mortality (0.04% vs 0.2%; relative risk, 0.27; 95% confidence interval, 0.09-0.76).

Conclusion: This meta-analysis of 6 cohort studies demonstrates that elective induction of labor at 39 weeks, compared with expectant management beyond that gestational age, was associated with a significantly lower risk of cesarean delivery, maternal peripartum infection, and perinatal adverse outcomes, including respiratory morbidity, intensive care unit admission, and mortality.

Keywords: cesarean delivery; elective labor induction; labor induction; low risk; maternal complications; nulliparity; nulliparous; observational studies; perinatal complications.

PubMed Disclaimer

Comment in

  • Should we offer elective induction of labor to nulliparous women at 39 weeks?
    Sichitiu J, Desseauve D. Sichitiu J, et al. Am J Obstet Gynecol. 2019 Sep;221(3):288. doi: 10.1016/j.ajog.2019.05.048. Epub 2019 Jun 11. Am J Obstet Gynecol. 2019. PMID: 31277807 No abstract available.
  • Reply.
    Grobman WA, Caughey AB. Grobman WA, et al. Am J Obstet Gynecol. 2019 Sep;221(3):288-289. doi: 10.1016/j.ajog.2019.05.049. Epub 2019 Jun 10. Am J Obstet Gynecol. 2019. PMID: 31277808 No abstract available.

MeSH terms